Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Chemoprevention of Skin SCC
NCT02347813Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Nov 2014
- Primary completion
- Jun 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of pioglitazone in squamous cell carcinoma of the skin (SCC), sponsored by University of Rochester. Started Nov 2014; status: completed.
02
Drugs
pioglitazone
03
Conditions
squamous cell carcinoma of the skin (SCC)
Beyond the preview
Go deeper on NCT02347813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02347813.